Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Liabilities from Discontinued Operations: 2017

Historic Expense - Real Estate for Fortress Biotech (FBIO) over the last 2 years, with Dec 2017 value amounting to $159.5 million.

  • Fortress Biotech's Liabilities from Discontinued Operations was N/A to $29.3 million in Q4 2017 from the same period last year, while for Dec 2017 it was $29.3 million, marking a year-over-year change of. This contributed to the annual value of $29.3 million for FY2017, which is N/A change from last year.
  • Per Fortress Biotech's latest filing, its Liabilities from Discontinued Operations stood at $29.3 million for FY2017.
  • Fortress Biotech's 5-year Liabilities from Discontinued Operations high stood at $29.3 million for FY2017, and its period low was $29.3 million during FY2017.
  • Its 2-year average for Expense - Real Estate is $85.0 million, with a median of $85.0 million in 2016.
  • Data for Fortress Biotech's Expense - Real Estate shows a peak YoY surged of 1,403.47% (in 2017) over the last 5 years.
  • Over the past 2 years, Fortress Biotech's Expense - Real Estate (Yearly) stood at $10.6 million in 2016, then soared by 1,403.47% to $159.5 million in 2017.